Pilot study of an online intervention for young people with a first psychotic episode: Thinkapp

  1. Morales-Pillado, C. 1
  2. Sanchez-Gutierrez, T.
  3. Barbeito, S. 1
  4. Mayoral, M. 2
  5. Arango, C. 2
  6. Leon, L. 3
  7. Ibañez, A. 3
  8. Rico, J. 4
  9. Calvo, A. 1
  1. 1 Universidad Internacional de La Rioja
    info

    Universidad Internacional de La Rioja

    Logroño, España

    ROR https://ror.org/029gnnp81

  2. 2 Hospital General Universitario Gregorio Marañón
    info

    Hospital General Universitario Gregorio Marañón

    Madrid, España

    ROR https://ror.org/0111es613

  3. 3 Hospital Ramón y Cajal
    info

    Hospital Ramón y Cajal

    Madrid, España

    ROR https://ror.org/050eq1942

  4. 4 AMAFE Foundation, Amafe, Madrid, Spain
Zeitschrift:
European Psychiatry

ISSN: 0924-9338 1778-3585

Datum der Publikation: 2022

Ausgabe: 65

Nummer: S1: Abstracts of the 30th European Congress of Psychiatry

Seiten: S321-S321

Art: Artikel

DOI: 10.1192/J.EURPSY.2022.817 GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: European Psychiatry

Zusammenfassung

Introduction: Online interventions can be a complement to maintain the long-term effectiveness of psychosocial interventions in First Episode Psychosis (FEP) that have already demonstrated their efficacy in the short and medium term (Calvo et al., 2015).Objectives: To test the effectiveness of a mobile app–based intervention (Thinkapp) to improve quality of life, functioning and symptomatology, and reduce days of admission and hospitalizations, in young people with FEP. Methods: Fourteen patients with FEP, aged 14–30, recruited from Gregorio Marañón Hospital, Ramón y Cajal Hospital and AMAFE Foundation in Madrid (Spain) received treatment as usual plus a psychoeducational intervention through a mobile app. Changes in dependent variables over the course of the intervention were assessed by means of a battery of clinical tests at baseline, 3-month and 6-month follow-up using a Wilcoxon test. Results: Of the fourteen patients included, 7 patients completed the 6-month follow-up and 8 completed the 3-month follow-up. There were significant differences in days of admission (p = 0.042) between baseline and 6-month follow-up. No significant results were observed in other clinical variables.